EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region

Ellie Jacoby iD, Dianna Quan, Emily Todd, Jonathan Shortt, Harry Smith, Nicholas Rafaels, Kristy Crooks, CCPM biobank Author Banner list

Muscle & Nerve · 2025

DOI: 10.1002/mus.28301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Ellie Jacoby und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Neuromuscular Section, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Prealbumin, Amyloid Neuropathies, Familial, Polymorphism, Single Nucleotide. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Hereditary transthyretin amyloidosis (ATTRv) is a genetic condition caused by pathogenic variants in the transthyretin ( TTR ) gene resulting in multisystem amyloid deposition, especially in peripheral nerve and heart. Information on the prevalence of ATTRv in the United States is limited. The objective of this study was to understand the prevalence and genetic ancestry in the Val142Ile population in a large regional US population.

Methods

Colorado Center for Personalized Medicine (CCPM) biobank collects specimens from consenting adults seen throughout the University of Colorado Health System, a large tertiary healthcare system within the Rocky Mountain Region (RMR). Single nucleotide polymorphism (SNP) array genotyping and whole exome sequencing (WES) were performed for genetic research. Prevalence of TTR variants was studied.

Results

A total of 73,346 participants had genetic testing; 151 (0.21%) individuals had a pathogenic or likely pathogenic TTR variant. The most common variant was Val142Ile, making up 82.61% of TTR variants found. Over four percent of people with African non‐Hispanic ancestry had a Val142Ile variant.

Discussion

The most common TTR variant in our study was Val142Ile, the most common variant in the United States (US). Similar to other US‐based studies, affected individuals were predominantly of African, non‐Hispanic ancestry. The availability of treatments for symptomatic ATTRv patients raises opportunities and challenges for biobanks as the identification of at‐risk individuals places pressure on highly specialized centers and providers to see patients for screening and follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrealbuminAmyloid Neuropathies, FamilialPolymorphism, Single NucleotideHumansFemaleMaleMiddle AgedAgedPrevalenceAdultColoradoAged, 80 and overGenetic VariationGenetic TestingExome Sequencing

Stichwörter der Autor:innen

TTR prevalenceVal142Ilegeneticshereditary amyloidosistransthyretin

Substanzen

PrealbuminTTR protein, human

Autor:innen und Institutionen

  • Neurology Department, Neuromuscular Section, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Colorado Center for Personalized Medicine, Aurora, Colorado, USA.
  • Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Ellie Jacoby

Zitieren

APA

Jacoby, E., Quan, D., Todd, E., Shortt, J., Smith, H., Rafaels, N., Crooks, K., & CCPM biobank Author Banner list (2025). Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle & Nerve. https://doi.org/10.1002/mus.28301

Vancouver

Jacoby E, Quan D, Todd E, Shortt J, Smith H, Rafaels N, et al. Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle & Nerve. 2025. doi:10.1002/mus.28301

BibTeX
@article{Jacoby2025,
  author = {Jacoby, Ellie and Quan, Dianna and Todd, Emily and Shortt, Jonathan and Smith, Harry and Rafaels, Nicholas and Crooks, Kristy and CCPM biobank Author Banner list, CCPM biobank Author Banner list},
  title = {Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.28301}
}
Kostenlos starten →